ISRCTN51803225进行中（未招募）1 期
Phase 1 trial HMR code: 22-017The full scientific title will be published within 30 months after the end of the trial.
eurocrine Biosciences (United States)0 个研究点目标入组 134 人开始时间: 2023年8月3日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 134
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Healthy human volunteers
排除标准
- •The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
研究者
相似试验
进行中（未招募）
1 期
Phase 1 trial HMR code: 21-017The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN17692710Alveron Pharma UK Ltd24
进行中（未招募）
1 期
Phase 1 trial HMR code: 23-011Healthy volunteersISRCTN17328380Asceneuron (Switzerland)16
进行中（未招募）
1 期
Phase 1 trial HMR code: 23-001Healthy volunteersISRCTN15245786Medherant Limited24
进行中（未招募）
1 期
Phase I trial HMR code: 23-007The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN10047421Gedeon Richter (Hungary)176
进行中（未招募）
1 期
Phase I trial, HMR code: 22-016Healthy volunteersISRCTN17231793xera Pharma UK Ltd104